85 related articles for article (PubMed ID: 11846992)
1. Comparative tissue-specific toxicities of 20 cancer preventive agents using cultured cells from 8 different normal human epithelia.
Elmore E; Luc TT; Steele VE; Redpath JL
In Vitr Mol Toxicol; 2001; 14(3):191-207. PubMed ID: 11846992
[TBL] [Abstract][Full Text] [Related]
2. The human epithelial cell cytotoxicity assay for determining tissue specific toxicity.
Elmore E; Luc TT; Steele VE; Kelloff GJ; Redpath JL
Methods Cell Sci; 2000 Mar; 22(1):17-24. PubMed ID: 10650329
[TBL] [Abstract][Full Text] [Related]
3. The human epithelial cell cytotoxicity assay for determining tissue specific toxicity: method modifications.
Elmore E; Siddiqui S; Desai N; Moyer MP; Steele VE; Redpath JL
Methods Cell Sci; 2002; 24(4):145-53. PubMed ID: 12843703
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of chemopreventive agents using cultured human prostate epithelial cells.
Wan XS; Zhou Z; Kennedy AR; Kopelovich L
Oncol Rep; 2003; 10(6):2009-14. PubMed ID: 14534735
[TBL] [Abstract][Full Text] [Related]
5. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
[TBL] [Abstract][Full Text] [Related]
6. New agents for cancer chemoprevention.
Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet RA; Doody LA; Malone WF; Hawk ET; Sigman CC
J Cell Biochem Suppl; 1996; 26():1-28. PubMed ID: 9154166
[TBL] [Abstract][Full Text] [Related]
7. Correlation of in vitro chemopreventive efficacy data from the human epidermal cell assay with animal efficacy data and clinical trial plasma levels.
Elmore E; Siddiqui S; Navidi M; Steele VE; Redpath JL
J Cell Biochem; 2005 Jun; 95(3):571-88. PubMed ID: 15786488
[TBL] [Abstract][Full Text] [Related]
8. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
9. Effect of 4-hydroxyphenylretinamide on human cervical epithelial and cancer cell lines.
Zou C; Vlastos AT; Yang Li; Wang J; Brewer M; Follen M
J Soc Gynecol Investig; 2003 Jan; 10(1):41-8. PubMed ID: 12517593
[TBL] [Abstract][Full Text] [Related]
10. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.
Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML
Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568
[TBL] [Abstract][Full Text] [Related]
11. The development of an anchorage-independence assay using human lung tumor cells to screen potential chemopreventive agents.
Korytynski EA; Kelloff GJ; Suk WA; Sharma S; Elmore E
Anticancer Res; 1996; 16(3A):1091-4. PubMed ID: 8702218
[TBL] [Abstract][Full Text] [Related]
12. Correlation of chemopreventive efficacy data from the human epidermal cell assay with in vivo data.
Elmore E; Luc TT; Li HR; Buckmeier JA; Steele VE; Kelloff GJ; Redpath JL
Anticancer Res; 2000; 20(1A):27-32. PubMed ID: 10769631
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.
Rao CV; Tokumo K; Rigotty J; Zang E; Kelloff G; Reddy BS
Cancer Res; 1991 Sep; 51(17):4528-34. PubMed ID: 1831401
[TBL] [Abstract][Full Text] [Related]
14. Difluoromethylornithine in combination with tamoxifen in female rats: 13-week oral toxicity study.
Brown AP; Morrissey RL; Crowell JA; Levine BS
Cancer Chemother Pharmacol; 1999; 44(6):475-83. PubMed ID: 10550568
[TBL] [Abstract][Full Text] [Related]
15. Chemopreventive drug development: perspectives and progress.
Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet R; Sigman CC
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):85-98. PubMed ID: 8118391
[TBL] [Abstract][Full Text] [Related]
16. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
Gupta S; Ahmad N; Marengo SR; MacLennan GT; Greenberg NM; Mukhtar H
Cancer Res; 2000 Sep; 60(18):5125-33. PubMed ID: 11016639
[TBL] [Abstract][Full Text] [Related]
18. Development and characteristics of a human cell assay for screening agents for melanoma prevention.
Elmore E; Jain A; Siddiqui S; Tohidian N; Meyskens FL; Steele VE; Redpath JL
Melanoma Res; 2007 Feb; 17(1):42-50. PubMed ID: 17235241
[TBL] [Abstract][Full Text] [Related]
19. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
Brewer M; Wharton JT; Wang J; McWatters A; Auersperg N; Gershenson D; Bast R; Zou C
Gynecol Oncol; 2005 Aug; 98(2):182-92. PubMed ID: 15907982
[TBL] [Abstract][Full Text] [Related]
20. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
Greenwald P
J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
